51 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Information relative au Code de Gouvernance (french) Lors de la réunion du Conseil d’administration du 16 décembre 2014, les |
Public releases | ||
Q3 2014 sales up 11.0% The Vétoquinol Group reported Q3 2014 sales of €82.2 million, up 11.0% compared to the same period last year (up 11.1% at constant exchange rates). |
Public releases | ||
Solid growth in Q2 2014: 8.8% first half net income up 4.2% At its July 30, 2014 meeting, the Vétoquinol S.A. Board of Directors reviewed the Group results and approved the financial statements for the first six months of 2014. |
Public releases | ||
Résultat du scrutin de l'Assemblée générale du 13 mai 2014 |
Shareholders´s Meeting | ||
Assemblée Générale Mixte du 13 mai 2014 : exercice 2013 |
Shareholders´s Meeting | ||
Convocation à l'Assemblée générale mixte du 13 mai 2014 |
Shareholders´s Meeting | ||
Formulaire Assemblée Générale du 13 mai 2014 |
Shareholders´s Meeting | ||
Assemblée générale mixte du 13 mai 2014 - exposé des motifs |
Shareholders´s Meeting | ||
Résultats des cinq derniers exercices |
Shareholders´s Meeting | ||
Vétoquinol and Bioniche Life Sciences Inc. close sale of Bioniche Animal Health business Lure, France and Belleville, Ontario, Canada, April 16, 2014 - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche’s Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in favour of the transaction. |
Public releases |